Sabby Management, LLC Purple Biotech Ltd. Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.15 $63,746 - $110,688	-26,672 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.45 - $4.3 $65,346 - $114,689	26,672 New	26,672 $105,000
Q3 2021 Nov 15, 2021	SELL	$4.4 - $5.59 $222,596 - $282,798	-50,590 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.75 - $6.72 $119,036 - $213,312	31,743 Added 168.42%	50,590 $247,000
Q1 2021 May 17, 2021	BUY	$3.93 - $6.99 $74,068 - $131,740	18,847 New	18,847 $78,000

2.64M

6.6K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $6.77M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.